ENTITYGovernmental or Regulatory ActivityGPE ‘Now is not the time to retreat’: BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge 3 days ago talkbio0Tagged Drug Industry, Health Care Reform, Home environment, Manufacturing, Myers, pharmaceutical manufacturing, pharmaceutical tariffs, squibb, Trump tariffs, U.S. BMS's $40B US Investment Amid Trump Administration's Pharmaceutical Policies Sources: